The DOI matches its Crossref record; 320 of the 320 references it cites were found in a registry or an index.
Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Open accessAbstract
This document updates and expands the initial Infectious Diseases Society of America (IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in 2002. It is intended as a guide for the use of antimicrobial agents in managing patients with cancer who experience chemotherapy-induced fever and neutropenia. Recent advances in antimicrobial drug development and technology, clinical trial results, and extensive clinical experience have informed the approaches and recommendations herein. Because the previous iteration of this guideline in 2002, we have a developed a clearer definition of which populations of patients with cancer may benefit most from antibiotic, antifungal, and antiviral prophylaxis. Furthermore, categorizing neutropenic patients as being at high risk or low risk for infection according to presenting signs and symptoms, underlying cancer, type of therapy, and medical comorbidities has become essential to the treatment algorithm. Risk stratification is a recommended starting point for managing patients with fever and neutropenia. In addition, earlier detection of invasive fungal infections has led to debate regarding optimal use of empirical or preemptive antifungal therapy, although algorithms are still evolving. What has not changed is the indication for immediate empirical antibiotic therapy. It remains true that all patients who present with fever and neutropenia should be treated swiftly and broadly with antibiotics to treat both gram-positive and gram-negative pathogens. Finally, we note that all Panel members are from institutions in the United States or Canada; thus, these guidelines were developed in the context of North American practices. Some recommendations may not be as applicable outside of North America, in areas where differences in available antibiotics, in the predominant pathogens, and/or in health care–associated economic conditions exist. Regardless of venue, clinical vigilance and immediate treatment are the universal keys to managing neutropenic patients with fever and/or infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–320 of 320
de Fontbrune, F. S., Robin, M., Porcher, R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/521912 · Cited by 99
Control of Influenza A on a Bone Marrow Transplant Unit
Weinstock, D. M., Eagan, J. A., Malak, S. A., Rogers, M., Wallace, H., Kiehn, T. E., & Sepkowitz, K. A. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501726 · Cited by 99
Self-citationEarly Discharge of Low‐Risk Febrile Neutropenic Children and Adolescents with Cancer
Aquino, V. M., Tkaczewski, I., & Buchanan, G. R. (1997) · Clinical Infectious Diseases · doi:10.1086/514512 · Cited by 98
Diagnosis of Venous Access Port--Related Infections
Douard, M. C., Arlet, G., Longuet, P., Troje, C., Rouveau, M., Ponscarme, D., & Eurin, B. (1999) · Clinical Infectious Diseases · doi:10.1086/313444 · Cited by 98
Vellenga, E., Groot, C. A. U.-D., de Wit, R., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.619 · Cited by 96
Weisser, M., Rausch, C. R., Droll, A., Simcock, M., Sendi, P., Steffen, I., Buitrago, C., Sonnet, S., Gratwohl, A. A., Passweg, J. R., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/444462 · Cited by 95
van de Wetering, M. D., de Witte, M. A., Kremer, L. C. M., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.006 · Cited by 94
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever
Hidalgo, M. M., Hornedo, J., Lumbreras, C., Trigo, J. M., Colomer, R., Perea, S., G�mez, C., Ruiz‐Casado, A., García‐Carbonero, R., & Cort�s-Funes, H. (1999) · Cancer · Cited by 94
Flynn, P. M., Shenep, J. L., & Barrett, F. F. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.5.1045-1046.1988 · Cited by 92
Shenep, J. L., Flynn, P. M., Baker, D. K., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/317552 · Cited by 92
Cruciani, M., Malena, M., Bosco, O., Nardi, S., Serpelloni, G., & Mengoli, C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.234 · Cited by 91
Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience
Thompson, G. R., Rinaldi, M. G., Pennick, G. J., Dorsey, S. A., Patterson, T. F., & Lewis, J. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00240-09 · Cited by 91
Prospective Study of Bacteremia and Complications With EUS FNA of Rectal and Perirectal Lesions
Levy, M. J., Norton, I. D., Clain, J. E., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.02.029 · Cited by 88
Rubinstein, E., Lode, H. M., Grassi, C., & Antibiotic Study Group (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1217 · Cited by 85
Catheter-Related Staphylococcus aureus Bacteremia in Cancer Patients
Ghanem, G., Boktour, M. R., Warneke, C. L., Pham-Williams, T., Kassis, C., Bahna, P., Aboufaycal, H., Hachem, R. Y., & RAAD, I. I. (2007) · Medicine · doi:10.1097/md.0b013e318030d344 · Cited by 85
Self-citationCorapcioglu, F. V., Sarper, N., & Zengin, E. (2006) · Pediatric Hematology and Oncology · doi:10.1080/08880010500506370 · Cited by 85
Timmer-Bonte, J. N. H., Adang, E., Smit, H. J. M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3281 · Cited by 85
Oral administration of cefixime to lower risk febrile neutropenic children with cancer
Paganini, H. R., Sarkis, C., Martino, M. G. D., Zubizarreta, P. A., Casimir, L., Fernández, C., Armada, A., Rodriguez-Brieshcke, M. T., & Debbag, R. (2000) · Cancer · Cited by 84
Home treatment of febrile neutropenia: An empirical oral antibiotic regimen
Gardembas-Pain, M., Desablens, B., Sensebé, L., et al. (1991) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057996 · Cited by 84
Vu, D., Peck, A. J., Nichols, W. G., Varley, C. D., Englund, J. A., Corey, L., & Boeckh, M. (2007) · Clinical Infectious Diseases · doi:10.1086/518985 · Cited by 83
Self-citationRisk Assessment and Treatment of Low-Risk Patients with Febrile Neutropenia
Kern, W. (2006) · Clinical Infectious Diseases · doi:10.1086/499352 · Cited by 81
-Lactam-Resistant Enterobacter Bacteremia in Febrile Neutropenic Patients Receiving Monotherapy
Johnson, M. P., & Ramphal, R. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.4.981 · Cited by 80
Zuckermann, J., Moreira, L. B., Moreira, L., et al. (2007) · Annals of Hematology · doi:10.1007/s00277-007-0390-7 · Cited by 75
Treatment of febrile neutropenic patients with cancer who require hospitalization
RAAD, I. I., Escalante, C. P., Hachem, R. Y., et al. (2003) · Cancer · doi:10.1002/cncr.11613 · Cited by 74
Self-citationAntifungal agents – clinical pharmacokinetics and drug interactions
Lipp, H. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01523.x · Cited by 73
Ramphal, R., Gucalp, R. A., Rotstein, C., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00113-1 · Cited by 71
Playford, E. G., Webster, A. C., Sorrell, T. C., & Craig, J. C. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0182-3 · Cited by 71
Biron, P., Fuhrmann, C., Curé, H., et al. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.4.511 · Cited by 70
Gómez, L., Garau, J., Estrada, C. M., et al. (2003) · Cancer · doi:10.1002/cncr.11044 · Cited by 69
Trifilio, S. M., Verma, A., & Mehta, J. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704423 · Cited by 69
Yamamura, D. L. R., Gucalp, R. A., Carlisle, P. S., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1704 · Cited by 69
RICHARD, D. A., Nousia‐Arvanitakis, S., Sollich, V., et al. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199706000-00007 · Cited by 67
Ullery, B. W., Pieracci, F. M., Rodney, J. R. M., et al. (2009) · Surgical Infections · doi:10.1089/sur.2008.061 · Cited by 67
Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients
Anaissie, E. J., Fainstein, V., Bodey, G. P., et al. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90140-4 · Cited by 66
Cherif, H., Björkholm, M., Engervall, P., et al. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410017590 · Cited by 66
Gaur, A. H., Flynn, P. M., Heine, D. J., Giannini, M. A., Shenep, J. L., & Hayden, R. T. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000160950.83583.7f · Cited by 62
Negative catheter-tip culture and diagnosis of catheter-related bacteremia.
Douard, M. C., Clementi, E., Arlet, G., et al. (1995) · PubMed · Cited by 62
Mustafa, M. M., Carlson, L., Tkaczewski, I., et al. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200103000-00036 · Cited by 61
Streptococcus pneumoniae Bacteremia in Patients With Cancer
Kumashi, P., Girgawy, E., Tarrand, J. J., et al. (2005) · Medicine · doi:10.1097/01.md.0000180045.26909.29 · Cited by 60
Persson, L. A., Söderquist, B., Engervall, P., et al. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00387.x · Cited by 59
Böhme, A., Shah, P. M., Stille, W., et al. (1998) · PubMed · Cited by 56
Chatzinikolaou, I., Hanna, H. A., Hachem, R. Y., Alakech, B., Tarrand, J. J., & RAAD, I. I. (2004) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.07.007 · Cited by 56
Self-citationProphylactic Antimicrobial Agents and the Importance of Fitness
Baden, L. R. (2005) · New England Journal of Medicine · doi:10.1056/nejme058133 · Cited by 56
Escalante, C. P., Weiser, M. A., Manzullo, E. F., Benjamin, R. S., Rivera, E., Lam, T. P., Ho, V., Valdres, R. U., Lee, E. L., Badrina, N., et al. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-004-0613-6 · Cited by 56
Self-citationCy, C., Tang, J., Hsueh, P., et al. (2004) · PubMed · Cited by 56
Kaye, K. S., Kanafani, Z. A., Dodds, A. E., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00060-06 · Cited by 54
Chemaly, R. F., Torres, H. A., Aguilera, E. A., Mattiuzzi, G. N., Cabanillas, M. E., Kantarjian, H. M., González‐Calle, V., Safdar, A., & RAAD, I. I. (2007) · Clinical Infectious Diseases · doi:10.1086/512374 · Cited by 54
Self-citationMaría Elena Santolaya de, P., Ricardo Rabagliati, B., Teresa Bidart, H., Ernesto Payá, G., D, A. M. G., Ricardo Morales, I., Stephanie Braun, J., Bronfman, L., Marcela Ferrés, G., Claudio Flores, P., et al. (2005) · Revista chilena de infectología · doi:10.4067/s0716-10182005000500001 · Cited by 53
Bacterial infections in low‐risk, febrile neutropenic patients
Kamana, M., Escalante, C. P., Mullen, C. A., et al. (2005) · Cancer · doi:10.1002/cncr.21144 · Cited by 52
Self-citationJones, G. R., Konsler, G. K., Dunaway, R. P., et al. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81358-7 · Cited by 52
Behre, G., Link, H., Maschmeyer, G., et al. (1998) · Annals of Hematology · doi:10.1007/s002770050366 · Cited by 51
Morris, P. G., Hassan, T. M., McNamara, M. G., et al. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-007-0398-5 · Cited by 51
Hodgson‐Viden, H., Grundy, P. E., & Robinson, J. L. (2005) · BMC Pediatrics · doi:10.1186/1471-2431-5-10 · Cited by 50
β-Lactam regimens for the febrile neutropenic patient
Bodey, G. P., Fainstein, V., Elting, L. S., Anaissie, E. J., Rolston, K. V. I., Khardori, N. M., Kantarjian, H. M., Plager, C., Murphy, W. K., Holmes, F. A., et al. (1990) · Cancer · Cited by 50
Self-citationChemaly, R. F., Hanmod, S. S., Jiang, Y., Rathod, D. B., Mulanovich, V. E., Adachi, J. A., Rolston, K. V. I., RAAD, I. I., & Hachem, R. Y. (2009) · Medicine · doi:10.1097/md.0b013e3181af01fc · Cited by 48
Self-citationFritsche, T. R., Sader, H. S., & Jones, R. N. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00114-7 · Cited by 48
Gill, S. I., Carney, D. A., Ritchie, D., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp297 · Cited by 48
Bruckner, L. B., & Gigliotti, F. (2006) · Seminars in Pediatric Infectious Diseases · doi:10.1053/j.spid.2006.06.008 · Cited by 47
Winston, D. J., Lazarus, H. M., Beveridge, R. A., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/318500 · Cited by 47
Aubron, C., Poirel, L., Fortineau, N., et al. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.254 · Cited by 46
Lehrnbecher, T., Stanescu, A., & Kühl, J. (2002) · Infection · doi:10.1007/s15010-002-2094-1 · Cited by 46
Johnson, P. R. E., Yin, J., & Tooth, J. A. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.2.203 · Cited by 46
Wingard, J. R., & Elmongy, M. B. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.01.003 · Cited by 44
Self-citationFever of Unknown Origin in Febrile Leukopenia
Antoniadou, A., & Giamarellou, H. (2007) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2007.08.008 · Cited by 44
Is Monotherapy for Febrile Neutropenia Still a Viable Alternative?
Ramphal, R. (1999) · Clinical Infectious Diseases · doi:10.1086/598623 · Cited by 43
Brauers, J., Frank, U., Kresken, M., Rodloff, A. C., & Seifert, H. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01015.x · Cited by 43
Impaired gut function as risk factor for invasive candidiasis in neutropenic patients
Blijlevens, N. M. A., Donnelly, J. P., & Pauw, B. E. D. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03394.x · Cited by 42
Falcone, M., Micozzi, A., Pompeo, M. E., Baiocchi, P., Fabi, F., Penni, A., Martino, P., & Venditti, M. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.6.540 · Cited by 41
Rolston, K. V. I., Manzullo, E. F., Elting, L. S., et al. (2006) · Cancer · doi:10.1002/cncr.21908 · Cited by 41
Self-citationPERIPHERAL VS. CENTRAL BLOOD CULTURES IN PATIENTS ADMITTED TO A PEDIATRIC ONCOLOGY WARD
Adamkiewicz, T. V., Lorenzana, A., Doyle, J., et al. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199906000-00018 · Cited by 41
The Value of Skin Biopsies in Febrile, Neutropenic, Immunocompromised Children
Allen, U. (1986) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1986.02140190069028 · Cited by 40
Wang, F., Liu, C.-Y., Hsu, H., et al. (1999) · Chemotherapy · doi:10.1159/000007228 · Cited by 40
Martino, R., Subirá, M., Altés, A., et al. (1998) · Acta Haematologica · doi:10.1159/000040840 · Cited by 39
Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients
Vandercam, B., Gérain, J., Humblet, Y., et al. (2000) · Annals of Hematology · doi:10.1007/s002770050571 · Cited by 39
Vancomycin-resistant enterococcal infections in bone marrow transplant recipients
Koç, Y., Snydman, D. R., Schenkein, D. S., et al. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701303 · Cited by 39
Freifeld, A. G., Sankaranarayanan, J., Ullrich, F. A., et al. (2007) · Supportive Care in Cancer · doi:10.1007/s00520-007-0308-x · Cited by 38
Self-citationCunha, B. A. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.07.007 · Cited by 38
Ragnar Lindblad, S. R. (1998) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365549850160864 · Cited by 38
Akova, M., Akan, H., Korten, V., et al. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00096-5 · Cited by 36
Velasco, E. D., da Costa, M. A. D. L., Martins, C. A. S., et al. (1995) · American Journal of Clinical Oncology · doi:10.1097/00000421-199510000-00014 · Cited by 34
Cornely, O. A., Wicke, T., Seifert, H., et al. (2004) · International Journal of Hematology · doi:10.1007/bf02983537 · Cited by 34
Mantadakis, E., Amoiridis, G., Kondi, A., et al. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e318030d289 · Cited by 32
Oğuz, A., Karadeniz, C., Çıtak, E. Ç., et al. (2006) · Pediatric Hematology and Oncology · doi:10.1080/08880010500506867 · Cited by 29
Antibacterial Prophylaxis in Patients with Cancer and Neutropenia
Freifeld, A. G., Sepkowitz, K. A., Martino, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc052613 · Cited by 28
Self-citationSpanik, S., Novotný, J., Mateicka, F., et al. (1999) · Journal of Infection and Chemotherapy · doi:10.1007/s101560050031 · Cited by 28
Nucci, M., Landau, M., Silveira, F., et al. (2001) · Infection Control and Hospital Epidemiology · doi:10.1086/501839 · Cited by 28
Molina, J., Sánchez‐García, J., Torres, A., Alvarez, M. A., Serrano, J., Casaño, J., Gómez, P., Martínez, F., Rodríguez, A., & Martín, C. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.09.007 · Cited by 27
Horowitz, H. W., Holmgren, D., & Seiter, K. P. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609054816 · Cited by 27
High dose intravenous ciprofloxacin in febrile neutropenic patients
Johnson, P. R. E., Yin, J. A. L., & Tooth, J. A. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/26.suppl_f.101 · Cited by 27
The treatment of febrile neutropenia: from the Dark Ages to the present
Bodey, G. P. (1997) · Supportive Care in Cancer · doi:10.1007/s005200050091 · Cited by 26
Empirical antifungal therapy in selected patients with persistent febrile neutropenia
Aguilar‐Guisado, M., Espigado, I., Cordero, E., Noguer, M., Parody, R., Pachón, J., & Cisneros, J. M. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.125 · Cited by 26
Imaging of the gastrointestinal complications of systemic chemotherapy
Cronin, C. G., O’Connor, M., Lohan, D. G., et al. (2009) · Clinical Radiology · doi:10.1016/j.crad.2009.02.016 · Cited by 26
Timmer-Bonte, J. N. H., Adang, E., Termeer, E. H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.0898 · Cited by 26
Burgess, D. S., Hall, R. G., & Hardin, T. C. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00036-1 · Cited by 25
Granulocyte colony-stimulating factors: finding the right indication
Lyman, G. H., & Shayne, M. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3281a3c0ba · Cited by 25
Gruson, D., Hilbert, G., Pigneux, A., et al. (1998) · PubMed · Cited by 25
von Lilienfeld‐Toal, M., Schneider, A., Orlopp, K. S., et al. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0081-2 · Cited by 24
Grazziutti, M., Dong, L., Miceli, M. H., Cottler‐Fox, M., Krishna, S. G., Fassas, A., van Rhee, F., Barlogie, B., & Anaissie, E. J. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705251 · Cited by 24
Cloutier, R. L. (2009) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2009.04.002 · Cited by 24
RAAD, I. I., Abi-Said, D., Rolston, K. V. I., Karl, C. L., & Bodey, G. P. (1998) · Cancer · Cited by 23
Self-citationMarra, C. A., Frighetto, L., Quaia, C. B., et al. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.11.931.35258 · Cited by 22
Özyılkan, Ö., Yalcintas, U., & Baskan, S. (1999) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.1999.14.2.15 · Cited by 21
Cellular expression of MDM2 and p53 in childhood leukemias with poor prognosis
Gustafsson, B. M., Christenson, B., Gustafsson, B., Hjalmar, V., & Winiarski, J. H. (2000) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(200002)34:2<87::aid-mpo2>3.0.co;2-f · Cited by 20
Adams, J. R., Angelotta, C., & Bennett, C. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6812 · Cited by 20
Vancomycin does not benefit persistently febrile neutropenic people with cancer
Wade, J. C., & Glasmacher, A. G. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.11.008 · Cited by 20
Verma, N., Clarke, R. W., Bolton‐Maggs, P. H. B., et al. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3180f61b81 · Cited by 19
Linezolid-Related Pancytopenia in Organ-Transplant Patients: Report of Two Cases
Faguer, S., Kamar, N., Fillola, G., et al. (2007) · Infection · doi:10.1007/s15010-007-6197-6 · Cited by 18
Egermayer, P., & Frampton, C. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.484 · Cited by 17
Pauw, B. E. D., & Rubin, R. H. (2006) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2006.00123.x · Cited by 15
Pauw, B. E. D., & Donnelly, J. P. (2009) · Clinical Infectious Diseases · doi:10.1086/597396 · Cited by 15
Carbapenem resistance in Canada
Toye, B., Krajden, S., Fuksa, M., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090167 · Cited by 14
Engervall, P., Kalin, M., Dornbusch, K., et al. (1999) · Journal of Chemotherapy · doi:10.1179/joc.1999.11.4.278 · Cited by 13
Empirical versus Preemptive Antifungal Therapy for Fever during Neutropenia
Marr, K. A., Leisenring, W. M., & Bow, E. J. (2009) · Clinical Infectious Diseases · doi:10.1086/605601 · Cited by 11
Self-citationApproach to the Patient with Prolonged Granulocytopenia
Pizzo, P. A. (1993) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-84899-5_5 · Cited by 10
Garrison, M. W. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.08.010 · Cited by 8
Emergence of linezolid-resistant enterococci in a neutropenic patient
Mehta, S. J., Johnson, J. K., Venezia, R. A., et al. (2005) · Journal of Hospital Infection · doi:10.1016/j.jhin.2005.05.008 · Cited by 7
Nguyen, T. D., Williams, B., & Ocampo, N. (2009) · Clinical Infectious Diseases · doi:10.1086/603588 · Cited by 6
Prophylactic application of fluoroquinolones for selective decontamination of the gut: friend or foe
van Belkum, A., & Vos, M. D. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1282-1 · Cited by 5
Mortality Associated with Cefepime Therapy among Neutropenic Patients
Gómez, L., Quintana, S., & Garau, J. (2009) · Clinical Infectious Diseases · doi:10.1086/605535 · Cited by 4
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Groll, A. H., Castagnola, E., Cesaro, S., Dalle, J.-H., Engelhard, D., Hope, W., Roilides, E., Styczynski, J., Warris, A., & Lehrnbecher, T. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70017-8 · Cited by 407
Schiffer, C. A., Mangu, P. B., Wade, J. C., Camp-Sorrell, D., Cope, D. G., El-Rayes, B. F., Gorman, M., Ligibel, J., Mansfield, P., & Levine, M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.5733 · Cited by 368
Montassier, E., Batard, E., Gastinne, T., Potel, G., & Cochetière, M. F. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1819-7 · Cited by 304
Metadata
- Authors
- Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-15
- Volume
- 52
- Issue
- 4
- Pages
- 427-431
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2096598041
- Cited by
- 704
- References
- 320
- FWCI
- 22.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.